New data have downgraded the power of Merck’s experimental COVID-19 pill to reduce hospitalization and death risks from 50% to 30%, STAT reports.

It was only a matter of time.  

As Americans prep for Thanksgiving on Thursday, they head into the national holiday worried, angry, confused, and missing absent loved ones.  

The pandemic has worsened depression and anxiety among 4,633 patients surveyed by a Utah health system.  

All the talk of global solidarity in the face of COVID-19 rings hollow. International medical partners who evacuated left Ugandans under-equipped and alone, according to a trio of Ugandan researchers from Mbarara University of Science and Technology and Makere University…

Susanne Herold and colleagues saw it coming.  

In the early days of COVID-19, grim photos of crowded hospitals and overflowing morgues rattled the world. But most of these images were coming from outside the US—some journalists say they had an easier time accessing war zones than US hospitals.   Only a small number of…

Progress against antimicrobial resistance has been slow, and COVID-19 has made things worse, according to a WHO/UN survey. 

Pfizer is moving ahead with its new COVID-19 pill, seeking emergency use authorization in the US and inking a licensing deal to allow 95 lower-income countries access to generic versions of the medication.  

A new study that found SARS-CoV-2 spreading quickly through the white-tailed deer population in the middle of the US spells bad news for any hopes of eliminating the virus.